Mordor Intelligence has published a new report on the Cell Therapy Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global cell therapy market is projected to grow from USD 5.58 billion in 2025 to USD 12.27 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.05% during the forecast period. This growth is fueled by the increasing prevalence of chronic diseases, heightened acceptance of regenerative medicine, and a surge in clinical research focused on cellular therapy advancements.
Chronic conditions such as diabetes and cancer are on the rise globally. For instance, approximately 500 million adults worldwide were diagnosed with diabetes in 2023, a number projected to rise to 1.3 billion by 2050. Similarly, new cancer cases are anticipated to exceed 35 million by 2050, marking a 77% increase from 2022. These escalating health challenges underscore the growing demand for effective cell therapies.
Cell Therapy Market Key Trends
-
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic ailments like diabetes and cancer is a significant driver for the cell therapy market. As traditional treatments often fall short, patients and healthcare providers are turning to cell-based therapies for more effective solutions.
-
Growth in Clinical Research
There is a notable uptick in clinical studies aimed at developing advanced cellular therapies. For example, in October 2023, Caribou Biosciences Inc. received FDA approval for an investigational new drug application for an allogeneic cell therapy targeting relapsed/refractory acute myeloid leukemia. Similarly, Seattle Children’s Therapeutics initiated a phase-1 clinical trial in April 2023 for a CAR T-cell therapy addressing aggressive brain and spinal cord tumors in young patients.
-
Regional Market Dynamics
North America currently holds the largest share of the cell therapy market, attributed to its advanced healthcare infrastructure and significant investment in research and development. Conversely, the Asia-Pacific region is expected to experience the fastest growth, driven by increasing healthcare expenditures and rising awareness of regenerative medicine.
Cell Therapy Market Segmentation
The cell therapy market is segmented based on therapy type, application, and geography:
By Type
- Autologous
- Allogeneic
By Therapy Type
- Mesenchymal Stem Cell Therapy
- Fibroblast Cell Therapy
- Hematopoietic Stem Cell Therapy
- Other Therapies
By Application
- Musculoskeletal Disorders
- Malignancies
- Cardiovascular Diseases
- Dermatology and Wounds
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
This segmentation allows for targeted strategies to address specific needs within each category, ensuring comprehensive coverage options for various patient populations.
Explore Our Full Library of Healthcare Research Industry Reports – https://www.mordorintelligence.com/market-analysis/healthcare
Cell Therapy Market Key Players
Several companies are at the forefront of the cell therapy market, contributing to its growth through research, product development, and strategic collaborations:
- Corestem Inc.: Specializes in stem cell therapies, particularly for neurodegenerative diseases.
- Chiesi Farmaceutici S.p.A.: An international pharmaceutical company engaged in the research and development of innovative therapies.
- Tego Science: Focuses on regenerative medicine, offering products for skin regeneration and wound healing.
- Allogene Therapeutics Inc.: Develops allogeneic CAR T-cell therapies for cancer treatment.
- Takeda Pharmaceuticals: A global biopharmaceutical leader with a strong emphasis on cell therapy research and development.
These organizations are recognized for their extensive research initiatives and commitment to advancing cell therapy solutions.
Conclusion
The cell therapy market is on an upward trajectory, driven by the escalating burden of chronic diseases and the continuous advancements in clinical research. With a projected market size of USD 12.27 billion by 2030, the sector presents significant opportunities for innovation and investment. As healthcare systems worldwide grapple with complex health challenges, cell therapies offer promising avenues for effective and personalized treatment options.
Industry Related Reports
Autologous Cell Therapy Market: The Autologous Cell Therapy Market is Segmented by Therapy (Autologous Stem Cell Therapy and Autologous Cellular Immunotherapies), Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease and Others), Source (Bone Marrow, Epidermis and Others), End User (Hospitals, Research Centers and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
CAR T-Cell Therapy Market: The CAR T-Cell Therapy Market is Segmented by Types (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta, and Others), Application (Leukemia, Lymphoma, Multiple Myeloma, and Autoimmune Disorders, and Other Applications), End Users (Hospitals, Cancer Care Treatment Centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Cell Therapy Contract Development And Manufacturing Organization Market: The Cell Therapy Contract Development and Manufacturing Organization Market Report is Segmented by Services (Stem-Cell Based, Non-Stem-Cell Based, and Other Therapies), Source (Clinical and Commercial), Indication (Oncology, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders, and Other Indications), Phase (Phase I, Phase II, Phase III, and Phase IV), End User (Pharmaceutical & Biotechnology, Companies, Academics & Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Animal Stem Cell Therapy Market: The Animal Stem Cell Therapy Market Report is Segmented by Type (Allogeneic and Autologous), Application (Wound Healing, Osteoarthritis, Tendonitis, Inflammatory Bowel Disease, Leukemia, Bone Repair, and Others), Animal Type (Companion Animals and Livestock Animals), End User (Veterinary Hospital, Veterinary Clinics, Research Institutes), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/